 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Evolent Health, Inc. (EVH) provides clinical and administrative solutions to payers and providers in the United States. 
It operates in two segments, Evolent Health Services and Clinical Solutions.
The Evolent Health Services segment provides an integrated administrative and clinical platform for health plan administration and population health management.
It offers financial and administrative management services, such as health plan services, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients, population health performance that delivers patient-centric cost-effective care.
The Clinical Solutions segment offers specialty care management services support a range of specialty care delivery stakeholders during their transition from fee-for-service to value-based care, independent of their stage of maturation and specific market dynamics in oncology and cardiology; and holistic total cost of care improvement.
On August 2nd, EVH reported 2nd Quarter June 2022 earnings of $0.11 per share on revenue of $319.9 million. The consensus earnings estimate was $0.04 per share on revenue of $294.9 million. Revenue grew 44.1% on a year-over-year basis.
Shares are heading higher in an upward trading channel. Higher share prices are expected.
Entry Point: $34.00
Stop Loss: $32.00
Trading Range: $21.36 to $39.00
Target Price: $37.40
EVH closed at $37.70
